NPI Lens

Mohammad F. Katranji, DO

NPI 1215143300ActiveIndividual· Internal Medicine, Pulmonary Disease· Bay City, MI

Internal Medicine, Pulmonary Disease (DO) in Bay City, Michigan, licensed in MI, with an NPI issued in May 2007. Hikma Pharmaceuticals USA reported $1,875 in payments in 2024, mostly consulting fees.

Overview

NPI1215143300
StatusActive
Entity typeIndividual
CredentialDO
Sole proprietorNo
NPI issuedMay 15, 2007
Last updated in NPPESNov 28, 2012

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Pulmonary Disease Primary207RP1001X5101016598MI
Internal Medicine207R00000X5101016598MI

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$1,875 · 3 payments from 1 company

Top paying companies in 2024

CompanyAmountPayments
Hikma Pharmaceuticals USA$1,8753

What the 2024 payments were for

  • Consulting Fee$900.00 · 1 payment
  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$900.00 · 1 payment
  • Food and Beverage$74.92 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Pulmonary Disease providers in Bay City

All Internal Medicine, Pulmonary Disease providers in Michigan →